Clinical Outsourcing World Europe - list of speakers 

Tarminder Bains joined the pharmaceutical industry and outsourcing team at Glaxo Wellcome (GW) in 1999. Post merger under GlaxoSmithkline (GSK), he moved from a role of insourcing resources to outsourcing clinical services for development trials. After five and a half years at GSK and as part of natural progression (personal/professional...

Roderick Cameron is an Outsourcing professional who has served in the pharmaceutical and vaccines industry for over 10 years. Currently, he is Deputy Director of Outsourcing for Global Clinical Immunology group at Sanofi Pasteur. He manages a group of four outsourcing professionals that support testing of clinical immunology serology preformed at...

James Chennells is Head of Global Strategic Sourcing Pharma Development Services within the Bayer Healthcare procurement organization. James heads a team responsible for outsourcing of services to support the BayerSchering Pharmaceuticals Development orgainsation. James has a BSc in Biology from Southampton University and started his 14 years in ...

As Global Clinical Outsourcing Manager at Actelion Pharmaceuticals, based in Basel Switzerland, Peter is part of a small team that is responsible for strategic and tactical support of outsourced services for all phase II and III studies across the globe including CRO, IVRS/IWRS, Central lab, ECG and Imaging Services. He acts as the Global Alliance ...

Ms. Dietz is the category lead for R&D Clinical Research across the Johnson & Johnson Medical Device & Diagnostics (MD&D) sector. Her responsibilities include identifying and selecting preferred providers, developing outsourcing and functional capacity strategies, and maintaining key supplier relationships. Additionally she has accountability for...

Estrella began her ‘scientific odyssey’ at the University of Navarra, Spain, where she gained a PhD in Genetic Toxicology. Following this, Estrella held at post-doctoral position at ICI (now Astra Zeneca) in Macclesfield, UK. At ICI Estrella’s focus was on novel anti-tumor drugs in the pre-clinical phase. Subsequently Estrella returned to Spain...

Paula is Head of Development Strategic Sourcing , Novartis Pharma, formerly Head R&D Procurement, AstraZeneca and is Fellow and Vice President of the Chartered Institute of Purchasing and Supply. She is responsible for driving value in all external spend in the development of new medicines. A physicist & chartered control and electrical...

Tali Guy, Adv. is a member of the Israel Bar Association since 1998 and has 14 years of experience in commercial law, with an expertise in contracts. Tali joined Teva Pharmaceuticals Industries LTD in 2007 as an Associate General Legal Counsel. Her position includes supporting the global activities of the Global Branded Research & Development...

Michael Herschel was born in Germany and graduated and obtained his doctorate in Medicine from Heidelberg University in 1977. After post-doc years at the Harvard Medical School Department of Psychiatry and medical speciality training (he is a board-certified Clinical Pharmacologist), he joined the Pharmaceutical Industry in the 1980s. He has held...

Ian has 11 years experience in drug development during in which time he has worked for the UK Government, CROs and Pharmaceutical companies. His varied career includes positions such as laboratory scientist, CRA, Project Manager and Clinical Scientist. He has worked across a wide variety of therapeutic and geographic areas including...

Professor Jones is a Director of Allergan Inc (USA) and R&D Director of Sigma-Tau S.p.A (Italy).He is Chairman of the UK stem cell biotech company ReNeuron plc , the International CRO Synexus Ltd, a member of the Boards of NextPharma Technologies Ltd ,SciClone Pharmaceuticals Inc (USA) , VeronaPharma plc.and Tecnogen S.p.A He is a visiting...

Dennis gained a PhD in Pharmacology before joining the industry as a CRA and held clinical research operational and management roles of increasing responsibility in several pharmaceutical companies and a CRO before joining Pfizer UK as Head of Clinical Research in 1999. In his current role Dennis is responsible for Phase II-IV clinical research...

Jeffrey S. Kasher, Ph.D., was named vice president and chief operating officer, global clinical development for Eli Lilly and Company in February 2007. He received a bachelor of science degree in chemistry from Franklin & Marshall College (Lancaster, Pa), a doctorate in pharmacology from the State University of New York (Syracuse) and a...

David Kim heads the Vendor Strategy and Management group within Merck & Co. He oversees his teams in all aspects of outsourcing activities which includes alliance management, vendor qualification, study level vendor management, vendor payments, and consultant agreement management. He started his Pharma career at Merck and then held positions in...

Maria has a BSc (Hons) Pharmacology, she started in the Pharmaceutical industry in 1989 as a Clinical Data Manager at Cyanamid UK. After time in a similar CDM role at Glaxo she joined the CRO sector as a Manager of CDM at ClinTrials Research. In 1994 she moved to IBAH (now Omnicare) to head up the CDM group and then the Project Management...

Graduated in Medicine from the University of Sao Paulo - Brazil, and specialized in Infectious Diseases. After working in academia, joined the pharmaceutical industry at Merck Sharp Dohme in Brazil in 1984, first in Medical Marketing, then in Clinical Research. In 2001 transitioned into the CRO industry for almost 4 years, and then back to big...

Pasi is working in Global Clinical Development Affairs at Actelion overseeing the Actelion’s clinical development finances globally. In his role Pasi believes that by implementing a clear outsourcing strategy by using different outsourcing models based on the characteristics of the development program is the right way to reduce costs and gain...

I currently have operational accountability for all clinical research conducted for Eli Lilly and Company within Latin America, India, Russia, Turkey, Africa, the Middle East, Asia and Australia. This included the strategic placement of trials and the management of staff in the various countries that implement clinical research. I started my...

Lee Scheible, Sourcing Consultant, has been at Eli Lilly for 25 years of which 9 years were spent in the Lilly Research Laboratories focusing on various microbiological and then analytical chemistry projects. He then moved his focus to a clinical research role within Medical, Oncology. After focusing strictly on clinical research for 3 years, he ...

Judith Zwickel, has 15+ years of experience in the clinical trials industry. Judith joined Teva Pharmaceuticals Ind. in 2003 and is the Global Strategic Outsourcing Manager at Teva's Global Innovative Research and Development. She previously also held a position of a global clinical leader at Teva. Prior to joining Teva Judith gained 2 years of...